Search

everythinglearnresearchcommunity

for

Search:↓

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Standardized procedures are crucial for collecting and preparing biological samples to ensure accurate clinical metabolomics results.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Overweight women with PCOS are more likely to have excess male hormones.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Vertical sleeve gastrectomy improved metabolism, behavior, and reproduction in obese rats with PCOS.

High testosterone increases heart disease risk in women with PCOS.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

Most adult women with PCOS in Port Harcourt, Nigeria, have high levels of bad fats in their blood, especially younger women.

Human hair protein modifications could potentially indicate heart disease risk.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

More than half of the women with PCOS in Southern India had Metabolic Syndrome, with large waist circumference being the most common feature.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.